Effectiveness of tramadol/paracetamol compared with etoricoxib as postoperative analgesia in daycare surgery by Choy, Choy Y. & Isquandar, Adnan
Southern African Journal of Anaesthesia and Analgesia is co-published by Medpharm Publications, NISC (Pty) Ltd and Cogent, Taylor & Francis Group
South Afr J Anaesth Analg
ISSN 2220-1181           EISSN 2220-1173
© 2014  SASA
RESEARCH
Southern African Journal of Anaesthesia and Analgesia 2014; 20(3):155–159
Open Access article distributed under the terms of the
Creative Commons License [CC BY-NC-ND 4.0]
http://creativecommons.org/licenses/by-nc-nd/4.0
Introduction
Day care surgery is cost-eff ective and forms 70% of hospital-
based surgical procedures.1 Postoperative pain is one of 
the most common causes of delayed discharge, patient 
dissatisfaction and unnecessary hospital admission following 
day care surgery.1 
It is important for surgeons and anaesthetists to provide good 
pain control postoperatively and after the patient has been 
discharged home. Recently, it was shown that multimodal 
analgesia was a rational approach to pain management, and 
was more eff ective than analgesic drugs, with lesser adverse 
effects.1 The “balanced analgesia” technique, involving a 
combination of non-opioid analgesics and smaller doses of 
opioid and local anaesthetic for wound infi ltration or neural 
blockade, has become an increasingly popular approach for 
postoperative analgesia following day care surgery.1 
Another important aspect of preoperative preparation is patient 
education with respect to pain management and patient 
participation in order to enhance rapid recovery and a return 
to work. Patients need to understand the analgesic plan, and 
should be given suffi  cient instructions on how to problem solve 
with respect to pain management in order to manage their 
own pain eff ectively. Similarly, patients should be motivated to 
enhance postoperative rehabilitation by early ambulation to 
improve respiratory function with deep breathing and to clear 
secretions by coughing. 
Kehlet and Dahl recognised the important role of the 
anaesthetist in facilitating early postoperative recovery, and 
preventing a transition from acute to chronic pain by ensuring 
optimal intraoperative anaesthetic management, and adequate 
pain relief well into the postoperative period.2 Increasingly, 
more major procedures, e.g. laparoscopic cholecystectomy and 
orthopaedic procedures involving the shoulder or hand, are 
being performed as same-day surgery. Watson et al reported 
inadequate control of postoperative pain with paracetamol 
and codeine, especially after discharge.3 Fifty-five per cent 
of patients experienced severe pain up to seven days after 
shoulder surgery. Nonsteroidal anti-inflammatory drugs 
(NSAIDs) constitute approximately 10% of the non-opioid 
analgesics. Nonpharmacological methods of pain control, e.g. 
cold treatment to relieve postarthroscopy shoulder pain, are 
utilised by only 6% of patients. Watson et al found that only 
55% of their patients received simple instructions on analgesic 
use, and 56% of patients were unable to manage their own 
pain eff ectively. The majority of patients suff ered inadequate 
pain relief and interference with sleep and daily living activities. 
Forty per cent of the patients experienced analgesic-related 
adverse events.3 McHugh and Thoms, in a study on day surgery, 
reported that 88% of patients experienced pain at home after 
being discharged, and 21%, severe pain.4
In a pharmacological review, Raff a recommended the use of a 
combination of oral analgesics with diff erent mechanisms of 
action which off er added advantages to the patient. Using a 
combination produces increased tolerability and effi  cacy, and 
synergistically increased analgesic eff ects in certain situations.5 
Smith et al studied the effectiveness of a combination of 
tramadol and paracetamol for post-surgical pain and as an 
alternative analgesic to NSAIDs.6 
Tramadol has two mechanisms of action. It exhibits mild 
μ-opioid receptor binding and prevents noradrenaline and 
serotonin reuptake. This dual mechanism may explain the 
lower rates of abuse and respiratory depression than those 
experienced with other opioids. 7 The tramadol and paracetamol 
combination also increases benefit through enhanced 
pharmacokinetics when drugs with a different onset and 
duration of action are combined judicially.8 Paracetamol may 
have multiple mechanisms of action, believed to include the 
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inhibition of prostaglandin E2 release in the spinal cord and the 
inhibition of nitric oxide synthesis mediated by N-methyl-D-
aspartate or substance P.6 
Traditional NSAIDs, and more recently cyclo-oxygenase-2 (COX-
2) selective inhibitors, have also been used as postoperative 
analgesia after daycare surgery. Etoricoxib is one of the 
newer available COX-2 inhibitors for oral use. It inhibits the 
enzyme, COX, which catalyses the fi rst step in the pathway 
of prostanoids synthesis. Some of these are implicated in the 
pathogenesis of infl ammation and nociceptive pain.9 Liu et al 
found that preoperative use of etoricoxib 120 mg given orally 
was associated with a lower opioid requirement and better pain 
scores after day care gynaecological surgery.10 
The aim of this study was to evaluate the eff ectiveness of a fi xed 
tramadol/paracetamol combination compared with etoricoxib 
as postoperative analgesia following day care surgery. Although 
these drugs have been found to be effi  cacious and safe, not 
many studies have been conducted that directly compare 
etoricoxib with the tramadol/paracetamol combination. Day 
care surgery patients were chosen as usually they experience 
mild to moderate pain, and an oral analgesic is convenient for 
patients once they have been discharged home. 
Method
This prospective, randomised, single-blinded clinical trial was 
performed following approval from the Dissertation Committee 
of the Department of Anesthesiology and Intensive Care, 
Universiti Kebangsaan Malaysia Medical Centre (UKMMC), and 
the UKMMC Research Ethics Committee (Research No FF-305-
2011).
After obtaining written consent, 62 American Society of 
Anesthesiologists class I or II adult patients, who fulfilled 
the criteria for day care surgery, were included in the study. 
Exclusion criteria were morbid obesity and chronic alcohol or 
substance abuse, and patient contraindication to tramadol, 
paracetamol or etoricoxib. Based on randomised numbers, 
patients were divided into two groups. Group A patients were 
given etoricoxib, and group B patients, tramadol/paracetamol.
Patients were reviewed early in the morning during the 
preoperative assessment. A test drug was given one hour 
preoperatively. General anaesthesia was administered to 
patients, with standard monitoring. Intravenous (IV) access was 
secured prior to the induction of anaesthesia with IV fentanyl, 
given up to 2 μg/kg bolus. Intermittent boluses of IV fentanyl 
were used intraoperatively based on the clinical indication. 
Airway management involved the use of a laryngeal mask 
airway device. Other opioid or NSAIDs were not given during 
the surgery. Prophylaxis was administered for postoperative 
nausea and vomiting (PONV), and included IV dexamethasone 
4 mg and IV metoclopramide 10 mg. Balanced anaesthesia 
was maintained with air and oxygen mixed with sevofl urane, 
with a targeted minimum alveolar concentration value of  1. 
Fluids were calculated according to the duration of fasting 
and the defi cit replaced depending on the judgement of the 
anaesthetist. At the end of surgery, local infi ltration of the 
wound with levobupivacaine, based on a dosage of 2 mg/kg, 
was given by the surgeon. 
Pain assessment was carried out postoperatively in the recovery 
room, based on the pain score via the visual analogue score 
(VAS) card and pain relief score using the pain relief scale. 
Excessive pain was controlled with small multiple doses of IV 
fentanyl 25 μg. The pain score was documented and taken as 
a baseline after one hour, commencing from the end of the 
surgery. The subsequent pain score was documented until 
four hours postoperatively. The duration of the procedure was 
noted, as well as the number of patients who required rescue 
fentanyl, and the total fentanyl dosage used by each patient.
Upon discharge, demographic data and phone numbers were 
obtained from the patients. VAS cards and patient pain diary 
sheets were given to patients. Subsequent pain assessments 
took place at 6, 12, 24 and 48 hours. This was carried out by a 
single independent operator through a direct interview or 
by telephone after discharge. The patient was discharged 
with etoricoxib 120 mg daily, or tramadol/paracetamol 
(37.5 mg/325 mg) three times daily, according to the groups. 
During analysis, pain severity was based on the VAS scale. A 
pain relief scale was also used. Assessed pain parameters were 
total pain relief based on a numerical scale, whereby “0” was 
no relief and “4” was complete relief, as well as sum of pain 
intensity diff erences. Sum of pain intensity diff erences were 
derived from the total pain intensity diff erences calculated 
by subtracting each recorded pain intensity score from the 
baseline pain intensity score. These efficacy variables were 
calculated from the pain relief and pain intensity diff erences at 
1, 2, 3, 4, 6, 24 and 48 hours postoperatively. The sample size 
was calculated using PS: Power and Sample Size Calculations® 
version 3.
The response within each subject group was normally 
distributed with a standard deviation of 0.33 in a previous 
study.9 If the true diff erence in the experimental and control 
means was 0.35, 28 experimental subjects and 28 control 
subjects would need to be studied in order to reject the null 
hypothesis that the population means of the experimental 
and control groups are equal with probability (power) of 0.8. 
The type I error probability associated with the test of this 
null hypothesis is 0.05. Data analysis was performed using the 
chi-square test for nonparametric data and Student’s t-test 
for parametric data. A p-value < 0.05 was considered to be 
statistically significant. Data analysis was performed using 
SPSS® for Windows® version 20.
Results
Sixty-two patients were enrolled in the study. There were no 
significant differences between the two groups in terms of 
patient characteristics, such as gender, ethnicity, weight, height 
and BMI (Table 1). None of the patients withdrew from this study.








Mean age (years) 37.93 (12.27) 38.18 (13.87)
Sex
Male 10 (34.5) 9 (27.3)
Female 19 (65.5) 24 (72.7)
Race
Malay 21 (72.4) 19 (57.6)
Chinese 3 (10.3) 6 (18.2)
Indian 3 (10.3) 4 (12.1)
Others 2 (6.9) 4 (12.1)
Weight (kg) 61.26 (11.64) 60.90 (13.62)
Height (m)  1.60 (0.07) 1.58 (0.08)
Body mass index (kg/m2) 23.73 (3.88) 24.30 (4.87)




























Eff ectiveness of tramadol/paracetamol compared with etoricoxib as postoperative analgesia in daycare surgery 157
A large number of cases were excision biopsy of unilateral 
fi broadenoma, with a total of 20 cases (Table 2). The mean 
duration of the surgical procedures for the etoricoxib group 
was 85.7 [standard deviation (SD) of 39.5] minutes and 72.7 
(SD of 27.2) minutes for the tramadol/paracetamol group 
(p-value 0.35).
The sum of pain intensity diff erences for etoricoxib were 0.77 
(SD of 0.35) and 0.59 (SD of 0.31) for tramadol/paracetamol 
(p-value 0.14). Total pain relief with etoricoxib was 3.21 (SD 
of 0.68) and 3.69 (SD of 0.32) with tramadol/paracetamol 
(p-value  0.001). This was shown to be statistically signifi cant 
(Table 3). Seventeen patients in each group required rescue 
fentanyl in the recovery room. There was no difference 
between the two groups with regard to the mean total fentanyl 
requirement (p-value 0.89).
Figure 1 shows the mean pain score over time for both groups. 
There was no statistical diff erence between the two groups 
from the fi rst to the fourth hour. The mean pain score for the 
etoricoxib group and the tramadol/paracetamol group at the 
sixth hour was 0.89 and 0.35, respectively. This diff erence was 
statistically signifi cant, with a p-value of 0.03. 
There was a statistically signifi cant diff erence in the mean pain 
relief score from the fi rst to the fourth hour (p-value < 0.05) 
(Figure 2).
The side-effect profile is shown in Table 4. Some patients 
experienced more than one side-effect. Our study showed 
p-value < 0.05 for nausea and dizziness (p-value 0.001), 
Table 3: Analgesic efficacy measures and fentanyl requirements
Analgesic measures Etoricoxib Tramadol/paracetamol p-value
The sum of pain intensity differences 0.77 (0.35) 0.59 (0.31) 0.14
Total pain relief 3.21 (0.68) 3.69 (0.32) 0.001*
Rescue fentanyl (μg) 17 (58.6) 17 (51.5) 0.35
Total fentanyl (μg) 99.5 (16.6) 100.2 (21.5) 0.89
Values are expressed as mean ± standard deviation or numbers (%)
* significant p-value < 0.05
Table 4: Frequency of adverse events
Side-effects Etoricoxib Tramadol/paracetamol p-value
< 1 12 (41.4) 15 (45.5) 0.75
≥ 2 17 (58.6) 18 (54.5)
Nausea 5 (27.7) 18 (78.2) 0.001*
Dizziness 11 (61.1) 6 (26.1) 0.024*
Vomiting 8 (44.4) 4 (17.4) 0.059
Headaches 13 (72.2) 10 (43.5) 0.066
Somnolence 4 (22.2) 4 (17.4) 0.69
Values are expressed as numbers (%)
* significant p-value < 0.05
Table 2: Types of operative procedure and the duration of the operation 
Operative procedure Etoricoxib Tramadol/paracetamol
Excision biopsy of unilateral fibroadenoma 8 12
Open unilateral inguinal hernia repair 8 7
Excision biopsy of lipoma 5 4
Laparoscopic bilateral tubal ligation 3 2
Examination under anaesthesia for anal fistula 1 2
J stent removal and reinsertion 0 3
Unilateral nephrostomy tube insertion 1 0
Hysteroscopy and biopsy 1 0
Removal of radius implant 0 1
Removal of tibial external fixation 1 0
Excision biopsy of unilateral wrist ganglion 1 0
Removal of multiple radius K-wire 0 1
Secondary suturing 0 1
Duration of operation (minute) 85.7 (39.5) 72.7 (27.2)
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suggesting that more nausea was associated with tramadol/
paracetamol. Dizziness was signifi cantly more frequent in the 
etoricoxib group (p-value  0.024). Signifi cant diff erences were 
not found for other adverse events.
Discussion
In a national survey in the USA, Apfelbaum et al demonstrated 
that approximately 80% of a random sample of 250 patients 
experienced acute pain after surgery.11 They revealed 
that patients experienced more pain once they had been 
discharged and were at home.11 Unrelieved pain, prolonged 
recovery and minor anaesthetic complications often lead to 
unanticipated hospital admission following day care surgery, 
resulting in increased healthcare costs and unnecessary 
patient dissatisfaction.11-12  Shnaider and Chung found that 
the incidence of pain following day care surgery ranged from 
40–70%.  They found that as a predictor of postoperative pain, 
after a 90-minute operation, 10% of patients experienced 
severe pain, while the number of patients with severe pain 
increased twofold following a 120-minute operation.12 Pavlin 
et al found that unrelieved pain was a major factor in delayed 
recovery following a survey of 175 ambulatory surgical 
patients.13 They found that as more major procedures, e.g. 
pelvic laparoscopies and transvaginal uterine procedures, as 
well as more complicated plastic surgery, were performed in 
an ambulatory setting, postoperative pain control became 
more important. They reported that 24% of their patients 
experienced delayed phase 1 recovery because of severe pain.
Both etoricoxib and tramadol/paracetamol provide good 
analgesia for mild to moderate pain, although they use diff erent 
mechanisms.8 In their study on acute postoperative dental pain, 
Chang et al found that the requirement for rescue analgesia 
within six hours postoperatively ranged from 22–41%, and that 
the amount used was signifi cantly less in the etoricoxib group 
than it was in the oxycodone or acetaminophen group.14 In this 
study, the majority of patients underwent minor procedures, 
e.g. excision of fibroadenoma of the breast. Most patients 
experienced mild pain, and there was no signifi cant diff erence 
between the two groups with regard to the requirement for 
rescue fentanyl.
In our study, we showed that pain at home was adequately 
treated with analgesics given to both groups, although pain 
relief was signifi cantly better with tramadol/paracetamol in the 
early postoperative period. It may be diffi  cult to credit tramadol/
paracetamol as the use of fentanyl as rescue analgesia continued 
in the recovery room. Also, there was no diff erence between 
the two groups with regard to rescue analgesia requirements. 
We postulate that this may be owing to other factors, such as 
diff erences in pain perception and individual pain tolerance 
thresholds, varying socio-economic backgrounds and previous 
post-surgical experience.  
Smith et al reported that a combination of tramadol 
and paracetamol in an  approximate 1:8 ratio resulted in 
synergistically enhanced analgesia, when a lower dosage of 
each drug was given to achieve a similar analgesic eff ect.6 
Paracetamol acts quickly, with an onset time of 20 minutes, 
peaks rapidly, and then declines thereafter.6 By contrast, 
tramadol has an onset time of 50 minutes, followed by a plateau 
effect.6 This may explain the significantly better pain relief 
demonstrated by the tramadol/paracetamol group in this study 
in the fi rst four hours after surgery. 
Smirnov et al showed that etoricoxib provided insufficient 
analgesia in the fi rst few hours.9 Etoricoxib is slow in onset, 
with daily dosing, reaching peak effi  cacy 3–4 hours after oral 
administration.9,14 We did not fi nd any signifi cant diff erence in 
the sum of pain intensity diff erences between the two groups. 
Also, there was diffi  culty explaining the signifi cant diff erences in 
total pain relief between the two groups in the fi rst four hours. 
Perhaps a larger sample is needed to clarify this issue. 
A multimodal strategy for postoperative analgesia should 
begin prior to the surgical procedure.15 By activating multiple 
pain inhibitory pathways, combination analgesics can provide 
eff ective pain relief and lesser side-eff ects than an individual 
drug alone.16 We included local infi ltration of levobupivacaine 
up to 2 mg/kg, given by a surgeon. Pavlin et al demonstrated 
that pain scores were lower in patients who received local 
anaesthetic infi ltration at the wound site.13 In many studies, 
local anaesthetic agents have been shown to be useful in the 
management of postoperative pain.15 White emphasised the 
important role of non-opioid analgesics for postoperative 
analgesia following day care surgery in a review. Although 
opioids may be required for more severe pain, the judicial use of 
adjuvants used in combinaiton is the ultimate way of achieving 
success. Potentially useful options include ketamine, alpha 
2-adrenergic agents and adenosine.16
In terms of side-eff ects, nausea occured more frequently in the 
tramadol/paracetamol group than it did in the etoricoxib group, 
probably because of the tramadol. Tramadol exhibits mild 
μ-opioid receptor binding, and noradrenaline and serotonin 
reuptake inhibition.6,7 The use of an opioid is commonly 
associated with a higher rate of PONV.16,17 Schug et al reported 
that paracetamol plus tramadol showed a signifi cantly reduced 
incidence of adverse events, compared to tramadol alone.8 
However Jung et al demonstrated an extremely low incidence 
of PONV (3.1%), compared to that noted in previous reports.7 
Smirnov et al showed that the incidence of PONV was lower 
in the etoricoxib group, compared with placebo, in thyroid 
surgery.9 The incidence of nausea was much higher in this 
study, but significantly worse with the use of tramadol/
paracetamol. Cicconetti et al found that etoricoxib was an 
eff ective analgesic agent, with clinical advantages in terms of 
gastrointestinal safety and unimpaired platelet function in 
maxillofacial surgery.18 Liu et al also confi rmed that etoricoxib 
did not increase the risk of postoperative bleeding after day 
care gynaecological surgery.10 Dizziness is a less common side-
eff ect associated with the use of COX-2 inhibitors.9,14 Smirnov et 
al reported a 2.9% incidence of dizziness in the etoricoxib group 
with respect to pain management in thyroid surgery.9 The 
incidence of dizziness was much higher in this study, and was 
signifi cantly higher in the etoricoxib group than it was in the 
tramadol/paracetamol group. We postulated that the residual 
eff ects of general anaesthesia were the cause of this problem, 
although the incidence of somnolence did not support 
prolonged recovery from general anaesthesia. The cause of a 
higher incidence of dizziness in the etoricoxib group could not 
be established with certainty from the available data in our 
study. Again, the incidence of headaches was much higher in 
this study, although there was a comparable incidence in both 
groups, and it was not signifi cantly diff erent. The study sample 
was small as the study was not designed with enough power for 
secondary outcomes, such as the frequency of adverse eff ects. 
However, patients in this study did not experience problems 
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required readmission to hospital. None of the patients withdrew 
from this study because of adverse events.
In conclusion, successful pain management after day care 
surgery can be achieved with non-opioid analgesics. Tramadol/
paracetamol provided significantly better pain relief than 
etoricoxib in the early postoperative period.
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